Skip to the page
pepts.wiki

We are not doctors and nothing here is medical advice. Always consult a medical professional first. Why we say this

Licensed medicineStub

Semax

Synthetic ACTH(4-10) analogue

A heptapeptide analogue of a fragment of ACTH. It is a registered medicine in Russia and is not licensed in the United States or the European Union.

Reconstitution calculator

At a glance

Licensed medicine

A regulator has licensed it for at least one use, in at least one country. That says nothing about uses outside the license.

This page is a stub

The wiki has this compound's identity from the My-Pepts library, its standing, and what PubMed holds for it. The article, with its studies read and cited, is not written yet. Until it is, the counts below say how much research exists, not what it found.

How strong is the evidence

How far it has climbed

Every medicine climbs the same ladder. Most compounds never reach the top, and where one stands says how much its claims can carry.

  1. Licensed medicine: Semax

    A regulator has reviewed the trials and licensed it for a named use.

  2. Phase 3

    Large randomized trials, often thousands of people, against placebo or a standard treatment.

  3. Phase 2

    Mid-sized trials that measure dose against effect in people with the condition.

  4. Phase 1 and early human studies

    First studies in people: safety, and how the body handles it.

  5. Cells and animals

    Laboratory and animal work. An animal result is not a result in people.

210
papers on PubMed
49
of them in people
1
randomized trials
11
reviews

A count says how much has been published, not what it found. Counted on PubMed: 2026-11-16

Handling and reconstitution

From powder to a measured sample

The same four steps for any lyophilized vial. Laboratory handling, not use in a person.

  1. 1. Read the vial

    The label gives the mass of peptide in the vial, in milligrams. That number is the start of every calculation.

  2. 2. Add the diluent

    A measured volume of diluent goes in slowly, down the glass. Swirl gently; shaking can damage a peptide.

  3. 3. Work out the strength

    Concentration is mass divided by volume: 10 mg in 2 mL is 5 mg per mL.

  4. 4. Measure the sample

    Volume is the mass wanted divided by the concentration. On a U-100 syringe, 1 mL is 100 units.

The calculator below does the arithmetic and shows its working.

As powder

General practice for lyophilized peptides: keep the sealed vial frozen or refrigerated, dry and away from light, and follow the supplier's certificate of analysis.

In solution

Once in solution a peptide is kept refrigerated and used within the period the supplier states. A vial drawn from more than once needs a preserved diluent such as bacteriostatic water.

This is general practice for lyophilized peptides, not data on Semax itself. The batch's certificate of analysis and the supplier's sheet are the facts to go by. More on storage

Reconstitution calculator

Opens on vial sizes common for research peptides. Change any number. How the arithmetic works

Draw to

10 units

0.1 mL on a U-100 syringe

Concentration
2.5 mg/mL
Each unit holds
25 mcg
Samples in the vial
20
Sample
250 mcg

5 mg in 2 mL is 2.5 mg/mL. 250 mcg of that is 0.1 mL, which reads as 10 units. This is arithmetic for a vial of Semax; no amount here is a recommendation.

Semax: on PubMed

What PubMed held for Semax on November 16, 2026. A count says how much a compound has been studied, not what the studies found: how to read these numbers.

210
papers
49
in humans
4
clinical trials
1
randomized trials
2012: 7 papers122013: 11 papers2014: 7 papers142015: 7 papers2016: 5 papers162017: 9 papers2018: 4 papers182019: 3 papers2020: 7 papers202021: 9 papers2022: 4 papers222023: 3 papers2024: 4 papers242025: 8 papers2026: 9 papers so far26
Papers per year, 2012 to 2026. The most in one year: 11.

Most relevant on PubMed

Listed by PubMed's own relevance ranking, trials and reviews first. The wiki has not read these into the article unless they are also among its sources.

  1. [The efficacy of semax in the tretament of patients at different stages of ischemic stroke]

    TrialGusev EI, Martynov MY, Kostenko EV, et al. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2018. PMID 29798983

  2. [Effectiveness of semax in acute period of hemispheric ischemic stroke (a clinical and electrophysiological study)]

    TrialGusev EI, Skvortsova VI, Miasoedov NF, et al. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 1997. PMID 11517472

  3. [Evaluation of therapeutic effect of new Russian drug semax in optic nerve disease]

    TrialPolunin GS, Nurieva SM, Baiandin DL, et al. Vestnik oftalmologii, 2000. PMID 10741256

  4. [The study of chronic partial denervation and quality of life in patients with motor neuron disease treated with semax]

    Randomized trialSerdiuk AV, Levitskiĭ GN, Miasoedov NF, et al. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2007. PMID 18379501

  5. Functional Connectomic Approach to Studying Selank and Semax Effects

    StudyPanikratova YR, Lebedeva IS, Sokolov OY, et al. Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections, 2020. PMID 32342318

  6. Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions

    ReviewRahman OF, Lee SJ, Seeds WA Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews, 2026. PMID 41490200

  7. Semax, synthetic ACTH(4-10) analogue, attenuates behavioural and neurochemical alterations following early-life fluvoxamine exposure in white rats

    StudyGlazova NY, Manchenko DM, Volodina MA, et al. Neuropeptides, 2021. PMID 33418449

  8. Semax, an analog of ACTH((4-7)), regulates expression of immune response genes during ischemic brain injury in rats

    StudyMedvedeva EV, Dmitrieva VG, Limborska SA, et al. Molecular genetics and genomics : MGG, 2017. PMID 28255762

Search used: ("Semax"[tiab]). Run it on PubMed

Research links

Also in Cognitive

Sold in blends: Semax + Selank, Semax + Selank + DSIP